QRISK3低估慢阻肺患者心血管事件风险
结果显示慢阻肺患者心血管病发生率显著高于一般人群,观察到的10年风险平均比QRISK3预测高52%,65岁以下者高82%。提示QRISK3需在慢阻肺人群中验证和修订。
要点
- 慢阻肺患者心血管病发生率显著高于一般初级保健人群。
- QRISK3平均低估慢阻肺患者10年心血管风险约52%。
- 65岁以下慢阻肺患者风险被低估更明显,可达82%。
核心结论
- 慢阻肺患者心血管病风险显著高于QRISK3预测值,尤其在年轻患者中。
主要发现
- 心血管病发生率为每100人年3.53例事件。
- 女性心血管病标化发病比为1.71(95%CI 1.61至1.75),男性为1.62(95%CI 1.54至1.64)。
- 65岁以下患者标化发病比更高:女性2.13(95%CI 1.94至2.19),男性1.86(95%CI 1.74至1.90)。
- 观察到的10年心血管病风险平均比QRISK3预测值高52%(33.5% vs 22.1%)。
- 65岁以下患者观察到的10年风险比预测值高82%。
临床怎么用
- 临床评估慢阻肺患者心血管风险时,应意识到QRISK3可能低估风险,尤其对65岁以下患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients with chronic obstructive pulmonary disease (COPD) are at increased risk of cardiovascular disease (CVD). The extent to which the excess CVD risk is captured by risk factors in QRISK, a widely used CVD risk scoring tool, is not well studied. METHODS: We created an incidence cohort of diagnosed COPD patients from the United Kingdom (UK) Clinical Practice Research Datalink GOLD database (January 1998-July 2018). The outcome was a composite of fatal or non-fatal CVD events. Sex-specific age-standardised incidence ratios (SIR) were compared with values for the UK primary-care population. The observed 10-year CVD risk was derived using the Kaplan-Meier estimator and was compared with predicted 10-year risk from the QRISK3 tool. RESULTS: 13 208 patients (mean age 64.9 years, 45% women) were included. CVD incidence was 3.53 events per 100 person-years. The SIR of CVD was 1.71 (95% CI 1.61 to 1.75) in women and 1.62 (95%CI 1.54-1.64) in men. SIR was particularly high among patients younger than 65 years (women=2.13 (95% CI 1.94 to 2.19); men=1.86 (95% CI 1.74 to 1.90)). On average, the observed 10-year risk was 52% higher than QRISK predicted score (33.5% vs 22.1%). The difference was higher in patients younger than 65 years (observed risk 82% higher than predicted). CONCLUSION: People living with COPD are at a significantly heightened risk of CVD over and beyond their predicted risk. This is particularly the case for younger people whose 10-year CVD risk can be >80% higher than predicted. Risk scoring tools must be validated and revised to provide accurate CVD predictions in patients with COPD.
引用
- Amegadzie JE, Gao Z, Quint JK, et al. QRISK3 underestimates the risk of cardiovascular events in patients with COPD. Thorax. 2024. PMID: 38050168. doi:10.1136/thorax-2023-220615
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。